Recently added articles from Biotech Business Week:
Agios Publishes Groundbreaking Research in Nature Uncovering the New Role of IDH1 Gene Mutation in Brain Cancer.
Dec 07, 2009 ... Agios Pharmaceuticals announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. This breakthrough discovery shows that the mutated form of IDH1 produces a metabolite, ...
Scientists at University of Texas describe research in alcoholism.
Dec 07, 2009 ... According to a study from the United States, "Alcohol dependence is extremely common in patients with bipolar disorder and is associated with unfavorable outcomes including treatment nonadherence, violence, increased hospitalization, and decreased quality of life. While naltrexone is a ...
Research from Y.M.F. Marickar and colleagues has provided new data on allopurinol therapy.(Clinical report)
Dec 07, 2009 ... According to a study from Trivandrum, India, "In earlier studies, we have confirmed that in most patients with calcium oxalate stone formation, a combination of allopurinol and pyridoxine is best suited for treatment and prevention of the stone forming process. The objective of this study ...
Reports summarize Alzheimer disease research from Washington University.(Report)
Dec 07, 2009 ... According to a study from the United States, "Persistent postoperative cognitive decline is thought to be a public health problem, but its severity may have been overestimated because of limitations in statistical methodology. This study assessed whether long-term cognitive decline ...
Research from P.J. Lin and co-researchers in the area of Alzheimer disease published.
Dec 07, 2009 ... "Alzheimer disease and related dementias (ADRD) have become a major concern for Medicare because of the increasing prevalence rate and the associated high cost of care. This study investigated the extent of concentration and persistence in total health care expenditures and prescription ...